{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:05:42Z","timestamp":1768446342562,"version":"3.49.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Circular RNAs (circRNA) are involved in a variety of human heart diseases, however, circRNA expression profiles and circRNA-miRNA-mRNA regulatory network in human atrial fibrillation (AF) especially with valvular heart diseases (VHD) remain poorly understood. A high-throughput RNA sequencing was used to investigate the differentially expressed circRNAs in left atrial appendage from VHD patients with or without persistent AF. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed to predict the potential functions of the host genes of differentially expressed circRNA and their downstream targets. CircRNA\u2013miRNA-mRNA regulatory network was constructed to identify mechanisms underlying circRNAs. qRT-PCR and sanger sequencing were further performed to validate the results. Compared with sinus rhythm (SR) patients, there were 3094 upregulated and 4472 downregulated circRNAs in AF patients respectively. The expression of 10 most differentially expressed circRNAs (circ 255-ITGA7, circ 418-KCNN2, circ 13913-MIB1, circ 44670-BARD1, circ 44782-LAMA2, circ 81906-RYR2, circ 35880-ANO5, circ 22249-TNNI3K, circ 3136-TNNI3K, circ 56186-TNNI3K) between SR and persistent AF patients were verified by qRT-PCR. In addition, specific back-splicing sites of these circRNAs was confirmed by sanger sequencing. GO and KEGG pathway analysis indicated that cAMP signal pathway and Wnt signal pathway might play important role in the development of AF in VHD patients, which might be affected by circRNAs. This study provided a preliminary landscape of circRNAs expression profiles which are involved in persistent AF due to VHD, and established the possibility for future related researches in this field.<\/jats:p>","DOI":"10.3389\/fcvm.2020.597932","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:16:59Z","timestamp":1605849419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases"],"prefix":"10.3389","volume":"7","author":[{"given":"Xiyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoshun","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fudong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/europace\/euz220","article-title":"Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis","volume":"21","author":"Banerjee","year":"2019","journal-title":"Europace"},{"key":"B6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrg.2016.114","article-title":"Detecting circular RNAs: bioinformatic and experimental challenges","volume":"17","author":"Szabo","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: from the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbrc.2018.03.051","article-title":"Circular RNA expression profiles in placental villi from women with gestational diabetes mellitus","volume":"498","author":"Yan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cvr\/cvw250","article-title":"A landscape of circular RNA expression in the human heart","volume":"113","author":"Tan","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","article-title":"A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223","volume":"37","author":"Wang","year":"2016","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0151753","DOI":"10.1371\/journal.pone.0151753","article-title":"The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/cdd.2017.61","article-title":"Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Death Differ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/eurheartj\/ehw.001","article-title":"Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses","volume":"38","author":"Du","year":"2017","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/CIRCULATIONAHA.111.019935","article-title":"Management of atrial fibrillation in patients with structural heart disease","volume":"125","author":"Darby","year":"2012","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2009.10.046","article-title":"Reverse remodeling of the atria after treatment of chronic stretch in humans: implications for the atrial fibrillation substrate","volume":"55","author":"John","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.117.311081","article-title":"Translational challenges in atrial fibrillation","volume":"122","author":"Heijman","year":"2018","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.03.004","article-title":"Atrial fibrillation is associated with hypermethylation in human left atrium, and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats","volume":"184","author":"Donate Puertas","year":"2017","journal-title":"Transl Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"40377","DOI":"10.1038\/srep40377","article-title":"Methylome-wide association study of atrial fibrillation in framingham heart study","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrcardio.2014.178","article-title":"MicroRNAs and atrial fibrillation: mechanisms and translational potential","volume":"12","author":"Luo","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","article-title":"CircRNA: functions and properties of a novel potential biomarker for cancer","volume":"16","author":"Meng","year":"2017","journal-title":"Mol Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fgene.2016.00053","article-title":"Mini review: circular RNAs as potential clinical biomarkers for disorders in the central nervous system","volume":"7","author":"Lu","year":"2016","journal-title":"Front Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/aps.2018.35","article-title":"The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases","volume":"39","author":"Stepie\u0144","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3892\/mmr.2018.9695","article-title":"Characterization of circRNAassociated ceRNA networks in patients with nonvalvular persistent atrial fibrillation","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14744\/AnatolJCardiol.2018.35902","article-title":"Circular RNA expression profiles of persistent atrial fibrillation in patients with rheumatic heart disease","volume":"21","author":"Hu","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijcard.2019.04.072","article-title":"circRNA-miRNA cross-talk in the transition from paroxysmal to permanent atrial fibrillation","volume":"290","author":"Costa","year":"2019","journal-title":"Int J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-017-0630-y","article-title":"Circles reshaping the RNA world: from waste to treasure","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0962-8924(00)01800-6","article-title":"Calmodulin: a prototypical calcium sensor","volume":"10","author":"Chin","year":"2000","journal-title":"Trends Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCGENETICS.115.001323","article-title":"Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-encoded calmodulin variants in long QT Syndrome and functional characterization of a novel long QT syndrome-associated calmodulin missense variant, E141G","volume":"9","author":"Boczek","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e004161","DOI":"10.1161\/CIRCEP.116.004161","article-title":"Novel CPVT-associated calmodulin mutation in CALM3 (CALM3-A103V) activates arrhythmogenic Ca waves and sparks","volume":"9","author":"Gomez-Hurtado","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.hrthm.2016.05.009","article-title":"Arrhythmogenic calmodulin mutations impede activation of small-conductance calcium-activated potassium current","volume":"13","author":"Yu","year":"2016","journal-title":"Heart Rhythm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1172\/JCI70102","article-title":"Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes","volume":"124","author":"Greiser","year":"2014","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.11.071","article-title":"A potential relationship between gut microbes and atrial fibrillation: trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation","volume":"255","author":"Yu","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.597932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:17:00Z","timestamp":1605849420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.597932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2020.597932"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.597932","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"article-number":"597932"}}